Randomized Trials of Cancer Drugs Are For Yesterday
RCTs are expensive, slow and yield frustratingly limited information. (Nature Outlook)
Randomized Trials of Cancer Drugs Are For Yesterday Read More »
policy
A Call For More Research On Cancer’s Environmental Triggers
No question about cancer is more contentious than its causes.
A Call For More Research On Cancer’s Environmental Triggers Read More »
Actually, Many New Cancer Drugs May Be Helpful And Worth Trying
Perhaps the literature fails to capture the clinical value of oncology drugs. This could happen for several reasons.
Actually, Many New Cancer Drugs May Be Helpful And Worth Trying Read More »
We Need To Tame The Price Of New Cancer Drugs
Are unbridled profits necessary to drive medical innovation and progress?
We Need To Tame The Price Of New Cancer Drugs Read More »
Team Care Slashes Deaths From Pregnancy In Sickle Cell Anemia
Prior to the program’s start, maternal mortality for women with sickle cell disease exceeded 9% at the teaching hospital. With
Team Care Slashes Deaths From Pregnancy In Sickle Cell Anemia Read More »
How The 21st Century Cures Act Should Support Public Health
We need and can afford both: to raise the bar so that everyone has access to modern healthcare, and to
How The 21st Century Cures Act Should Support Public Health Read More »